PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 46 filers reported holding PASSAGE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,371,000 | -37.2% | 539,263 | -16.5% | 0.24% | -34.9% |
| Q2 2021 | $8,553,000 | -65.4% | 646,001 | -54.3% | 0.37% | -57.4% |
| Q1 2021 | $24,708,000 | -35.0% | 1,413,508 | -4.9% | 0.87% | -48.9% |
| Q4 2020 | $38,024,000 | +32.3% | 1,487,038 | -32.1% | 1.70% | +2.2% |
| Q3 2020 | $28,730,000 | -52.9% | 2,191,453 | -1.7% | 1.66% | -62.0% |
| Q2 2020 | $60,935,000 | +73.5% | 2,229,587 | 0.0% | 4.37% | +37.3% |
| Q1 2020 | $35,116,000 | – | 2,229,587 | – | 3.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |